Health Care/Hospital News & Press Release Distribution

MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition

AGC Biologics Now Provides End-to-End Cell and Gene Therapy CDMO Services SEATTLE, Oct. 28, 2020 /PRNewswire/ -- After its parent company AGC Inc. acquired 100% of the shares of MolMed S.p.A. onSeptember 30, 2020, AGC Biologics announced that MolMed's entity name has been changed to AGC Biologic...

2020-10-28 07:00 1975

PlanetWatch activates innovative air quality monitoring in two key Italian cities and announces grant from the Algorand Foundation

ST. GENIS-POUILLY, France, Oct. 28, 2020 /PRNewswire/ -- PlanetWatch , a French startup which is leveraging the Algorand blockchain to build a global air quality ledger, announced today that it has already activated over 100 sensors in the Ital...

2020-10-28 06:54 2088

Passive Immune Prophylaxis preventing COVID-19 with 'Acellular-Convalescent Plasma' (A-CP): a new technology introduced by Regen Lab®

Convalescent Plasma (CP), also called Passive Antibody Therapy for the treatment of COVID-19 infected patients was approved by the US-FDA on August 23, 2020! LAUSANNE, Switzerland, Oct. 27, 2020 /PRNewswire/ -- This great news was based on a nationwide evaluation in 14 US medical institutions. A...

2020-10-27 22:36 1369

Daewoong Pharmaceutical's Long-Acting Niclosamide Shows High Promise Against Upcoming COVID-19 'Twindemic'

SEOUL, South Korea, Oct. 27, 2020 /PRNewswire/ -- Daewoong Pharmaceutical, a South Korean pharmaceutical giant announced that its Covid-19 treatment candidate of sustained-release niclosamide (DWRX2003) also showed promising study results for a fight against the upcoming 'Twindemic' involving COV...

2020-10-27 21:00 1111

VeChain, Renji Hospital and DNV GL Held Strategic Partnership Signing Ceremony To Launch World's First Blockchain Intelligent Tumor Treatment Center

SHANGHAI, Oct. 27, 2020 /PRNewswire/ -- In partnership with VeChain and DNV GL, Renji Hospital, a top-ranked hospital inChinaaffiliated with the Shanghai Jiaotong University School of Medicine, has announced the launch of the world's first blockchain-enabled Intelligent Tumor Treatment Center on ...

2020-10-27 21:00 1809

VeChain, Renji Hospital and DNV GL Held Strategic Partnership Signing Ceremony To Launch World's First Blockchain Intelligent Tumor Treatment Center

Genome & Company announces first patient dosed in Phase 1/1b study of GEN-001, an immuno-oncology microbiome therapeutic, in combination with avelumab

* The first microbiome oncology therapeutic candidate developed by an Asia -based biotech successfully initiatesphase 1/1b clinical trial in the US, six months after its IND went into effect. * The first patient enrolled and treated at OHSU (Oregon Health & Science University Knight Cancer In...

2020-10-27 21:00 1263

Ping An Reports Steady Growth of 4.5% in Operating Profit Attributable to Shareholders of Parent Company in 9M 2020

HONG KONG and SHANGHAI, Oct. 27, 2020 /PRNewswire/ -- Ping An Insurance (Group) of Company ofChina, Ltd. (hereafter "Ping An" or the "Group" or the "Company", HKEx:2318; SSE:601318) today announced its results for the nine months ended30 September 2020. In the third quarter of 2020, China achiev...

2020-10-27 20:52 8837

NCCN Announces Beth Gaffney, MBA, as New Vice President of U.S. and Global Business Development

New executive will lead the National Comprehensive Cancer Network's programs for sharing evidence- and expert consensus-based resources to improve cancer care. PLYMOUTH MEETING, Pennsylvania, Oct. 27, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today announced the add...

2020-10-27 20:35 960

I-Mab to Present Preclinical Data of TJ210 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

SHANGHAI and GAITHERSBURG, Md., Oct. 27, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Company will present the latest preclinical dat...

2020-10-27 20:05 4439

TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm's history

- The Fund continues the proven "Project Focused Company" investment strategy for early-stage drug development candidates - In addition, the Fund continues to invest in late-stage clinical biopharmaceutical companies, medical device companies and diagnostic companies MUNICH and MONTREAL, Oct. 27...

2020-10-27 20:00 2248

Annual SEA Mental Health Forum finds partnerships, innovation, and access as key solutions to tackling positive correlation between mental illness and COVID-19

* Mental health conditions such as schizophrenia, depression and neurological disorders are exacerbated by the COVID-19 pandemic acrossSoutheast Asia markets * Utilization of telehealth and telepsychiatry, home delivery of medications, enhanced training support on primary level and advancement...

2020-10-27 16:23 3097

Annual SEA Mental Health Forum finds partnerships, innovation, and access as key solutions to tackling positive correlation between mental illness and COVID-19

Ratchaphruek Hospital Achieves GHA's COVID-19 Certification of Conformance for Medical Travel

WEST PALM BEACH, Florida, Oct. 27, 2020 /PRNewswire/ -- Ratchaphruek Hospital ( https://rph.co.th/en/), a top destination for medical travelers to Thailand, is the second hospital inThailand and the third hospital in the world to be awarded Global Healthcare Accreditation'sCertification of Conform...

2020-10-27 16:00 1690

Cytiva strengthens support to diagnostics industry with new labs, services and supply chain enhancements

* Now offering Cytiva Diagnostic Services, new diagnostic test development and support service virtually or at new lab, for point-of-care diagnostic developers to increase speed to market of new tests. * Supply chain enhancements include increasing inventory, investing in plants and expanding...

2020-10-27 16:00 2590

Sihuan Pharmaceutical (0460.HK) receives approval for its exclusive medical aesthetic product Letybo (botulinum toxin), A blockbuster product in a hundred-billion size market

HONG KONG, Oct. 27, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460) is pleased announce that "Type A Botulinum Toxin for Injection" (Letybo 100U), a product exclusively distributed by Sihuan Pharmaceutical, has officially received the marketing approval from the Natio...

2020-10-27 10:42 5792

Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study

MELBOURNE, Australia and SAN FRANCISCO, Oct. 26, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") today announced it has commenced enrolling patients with Multiple System Atrophy (MSA) in its bioMUSE Study inthe United States. BioMUSE is a natur...

2020-10-27 10:03 3374

VeChain, Renji Hospital and DNV GL Held Strategic Partnership Signing Ceremony To Launch World's First Blockchain Intelligent Tumor Treatment Center

SHANGHAI, Oct. 27, 2020 /PRNewswire/ -- In partnership with VeChain and DNV GL, Renji Hospital, a top-ranked hospital inChinaaffiliated with the Shanghai Jiaotong University School of Medicine, has announced the launch of the world's first blockchain-enabled Intelligent Tumor Treatment Center on ...

2020-10-27 09:00 2275

VeChain, Renji Hospital and DNV GL Held Strategic Partnership Signing Ceremony To Launch World's First Blockchain Intelligent Tumor Treatment Center

SHANGHAI, Oct. 27, 2020 /PRNewswire/ -- In partnership with VeChain and DNV GL, Renji Hospital, a top-ranked hospital inChinaaffiliated with the Shanghai Jiaotong University School of Medicine, has announced the launch of the world's first blockchain-enabled Intelligent Tumor Treatment Center on ...

2020-10-27 09:00 2406

Ortho's VITROS® SARS-CoV-2 Antigen Test Capable of Accurate Mass-Scale Testing Achieves CE Mark

RARITAN, New Jersey, Oct. 27, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its new VITROS® SARS-CoV-2 Antigen test, designed to detect active SARS-CoV-2 infection, achieved CE Mark for distribution throughout the EU. The company al...

2020-10-27 08:50 1124

Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Study of MDM2-p53 Inhibitor APG-115 in Combination with Immunotherapy for the Treatment of Patients with Advanced Liposarcoma or other Advanced Solid Tumors in China

SUZHOU, China and ROCKVILLE, Md., Oct. 27, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Eva...

2020-10-27 08:13 2132

Drawbridge Health Announces Partnerships to Fuel Expansion in Japan

MENLO PARK, Calif., Oct. 27, 2020 /PRNewswire/ -- Drawbridge Health, a healthcare technology company redefining the blood draw experience for both patients and healthcare providers, today announced a further investment from Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma") as w...

2020-10-27 08:00 1478